# Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo

> **NCT01309178** · PHASE2 · UNKNOWN · sponsor: **University Children's Hospital Tuebingen** · enrollment: 30 (estimated)

## Conditions studied

- Cystic Fibrosis
- Pneumonia

## Interventions

- **DRUG:** Amitriptyline
- **DRUG:** Mannite

## Key facts

- **NCT ID:** NCT01309178
- **Lead sponsor:** University Children's Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01309178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01309178, "Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01309178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*